February 8th, 2018 /
In the News
DOE/NNSA Partnership With U.S. Healthcare Industry Results in FDA Approval of Domestically-Produced, Non-Uranium Based Molybdenum-99
WASHINGTON – Efforts by the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA) to ensure a reliable supply of a vital medical isotope have paved the way for today’s announcement by the U.S. Food and Drug Administration (FDA) on the approval of the first domestically-produced, non-uranium based molybdenum-99 (Mo-99). Read more…
Questions?
Do you have questions about NorthStar, our products, supply solutions, careers or anything else?
